Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
1.970
-0.080 (-3.90%)
At close: Jun 27, 2025, 4:00 PM
2.030
+0.060 (3.05%)
After-hours: Jun 27, 2025, 7:20 PM EDT

Vistagen Therapeutics Market Cap

Vistagen Therapeutics has a market cap or net worth of $57.12 million as of June 27, 2025. Its market cap has decreased by -43.94% in one year.

Market Cap
57.12M
Enterprise Value
-21.85M
1-Year Change
-43.94%
Ranking
Category
Stock Price
$1.97

Market Cap Chart

Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $57.12M, an increase of 514.24%. That is a compound annual growth rate of 21.98%.

History

DateMarket Cap% Change
Jun 27, 202557.40M-30.09%
Dec 31, 202482.10M-40.89%
Dec 29, 2023138.90M552.11%
Dec 30, 202221.30M-94.53%
Dec 31, 2021389.40M171.17%
Dec 31, 2020143.60M381.88%
Dec 31, 201929.80M-36.05%
Dec 31, 201846.60M258.46%
Dec 29, 201713.00M-58.47%
Dec 30, 201631.30M236.56%
View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 713.81B
Johnson & Johnson 365.75B
AbbVie 329.95B
Novo Nordisk 299.93B
UnitedHealth Group 274.52B
Novartis AG 235.02B
Abbott Laboratories 232.56B
AstraZeneca 215.99B
Market Cap Rankings